Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma
| Conditions: | Mesothelioma |
| Start Date: | October 1, 2001 |
| Phase: | Phase III |
| Status: | Completed |
| NCT ID: | NCT00190762 |
| Study Type: | Interventional |
| Intervention: | Drug: Pemetrexed |
| Study Design: | Allocation: Randomized|Control: Active Control|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Eli Lilly and Company |
| Ages: | Adult|Senior |
| Enrollment: | 240 |
| Funded By: | Industry |
| First Received: | September 12, 2005 |
| End Date: | November 1, 2005 |
| Last Updated: | January 24, 2007 |
| Last Verified: | January 1, 2007 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
